Phase 1 Open-label Study to Evaluate Efficacy and Tolerability of TLC399 in Patients With Macular Edema Due to RVO
Condition(s):Central Retinal Vein Occlusion With Macular Edema; Branch Retinal Vein Occlusion With Macular EdemaLast Updated:December 23, 2021Completed